Floppy Iris Syndrome for NBEO and OKAP
Master intraoperative floppy iris syndrome: the tamsulosin link, classic triad and cataract surgery planning points tested on NBEO and OKAP.
Which triad characterizes intraoperative floppy iris syndrome?
Floppy Iris Syndrome in 30 Seconds
Intraoperative floppy iris syndrome is a cataract surgery complication marked by unstable iris behavior and progressive miosis. It is classically associated with tamsulosin, the selective alpha-1a adrenergic receptor antagonist used to treat benign prostatic hyperplasia. IFIS raises the risk of iris prolapse and makes phacoemulsification more difficult.
The Classic Triad
- Billowing, floppy iris stroma undulates with normal fluid currents. Exam relevance: this is the first triad feature.
- Iris prolapse occurs toward the phaco incisions. Exam relevance: recognize wound-directed iris movement.
- Progressive intraoperative pupil constriction occurs despite adequate dilation. Exam relevance: miosis completes the classic triad.
Drugs and Mechanism
- Tamsulosin: the alpha-1a antagonist most strongly associated with IFIS.
- Other alpha-1 blockers: alfuzosin, doxazosin, terazosin and silodosin carry lower risk. IFIS has also been reported less commonly with other agents.
- Mechanism: selective alpha-1a blockade reduces tone and is thought to cause atrophy of the iris dilator muscle.
- Persistence: the risk may persist for months or even years after discontinuation, so stopping the medication shortly before surgery does not reliably prevent IFIS.
- Use: alpha-1 blockers treat benign prostatic hyperplasia and some bladder conditions, so ask men and some women about these drugs.
4 Facts Exams Always Ask
- The IFIS triad is iris billowing, iris prolapse and progressive intraoperative miosis.
- Tamsulosin is the classic cause because alpha-1a blockade reduces tone and causes atrophy of the iris dilator muscle.
- Stopping tamsulosin preoperatively does not reliably prevent IFIS because its effect can be long lasting.
- A medication history should be shared with the surgeon so they can plan for pupil expansion devices, iris hooks, intracameral phenylephrine or viscoadaptive OVDs.
The Classic Trap
The main NBEO and OKAP trap is assuming that stopping tamsulosin before surgery prevents IFIS. It may persist long after discontinuation. Take a careful medication history before surgery so the surgeon can prepare. IFIS is a surgical management problem, not a reason to withhold needed alpha blockade, and patients should not stop tamsulosin without consulting the prescribing physician.
Clinical Pearl
The highest-yield step is identifying tamsulosin or another alpha-1 blocker during the preoperative medication history. Stopping therapy beforehand does not reliably prevent IFIS, and the ocular benefit of stopping is uncertain while urinary symptoms may worsen. Intraoperative strategies include pupil expansion rings, iris retractor hooks, intracameral phenylephrine, viscoadaptive ophthalmic viscosurgical devices and adjusted fluidics.
Checkpoint 1
Which medication is most strongly associated with intraoperative floppy iris syndrome, and by what mechanism?
Checkpoint 2
Does stopping tamsulosin shortly before cataract surgery reliably prevent intraoperative floppy iris syndrome?
A man scheduled for cataract surgery takes tamsulosin for benign prostatic hyperplasia. Which intraoperative problem should the surgeon anticipate, and what preoperative step best reduces surprise during surgery?
A man on tamsulosin for benign prostatic hyperplasia is scheduled for cataract surgery. What should the surgeon anticipate, and what step is most valuable?
Sources & Publisher Info
References
- AAO BCSC Section 11: Lens and Cataract.
- AAO BCSC Section 8: External Disease and Cornea.
- American Academy of Ophthalmology. EyeWiki: Intraoperative Floppy Iris Syndrome.
More Pharmacology topics
Ready for the real thing?
Practice thousands of eye-care questions free on OcuQuiz. Earn points, build streaks and battle colleagues.
Practice Pharmacology →